tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Technical Analysis

Compare
1,797 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbCellera Biologics’s (ABCL) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting AbCellera Biologics is a Sell.
AbCellera Biologics’s (ABCL) 20-Day exponential moving average is 2.53, while AbCellera Biologics’s (ABCL) share price is $3.2, making it a Buy.
AbCellera Biologics’s (ABCL) 50-Day exponential moving average is 2.41, while AbCellera Biologics’s (ABCL) share price is $3.2, making it a Buy.

AbCellera Biologics (ABCL) Pivot Points

Jun 15, 2025, 10:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.82
2.95
3.05
3.18
3.28
3.41
3.51
Fibonacci
2.95
3.04
3.09
3.18
3.27
3.32
3.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbCellera Biologics (ABCL) Moving Averages

Jun 15, 2025, 10:15 AM
Period
Simple
Exponential
MA5
3.02Buy
3.02Buy
MA10
2.68Buy
2.77Buy
MA20
2.35Buy
2.53Buy
MA50
2.31Buy
2.41Buy
MA100
2.55Buy
2.49Buy
MA200
2.66Buy
2.62Buy
AbCellera Biologics’s (ABCL) 10-Day exponential moving average is 2.77, while AbCellera Biologics’s (ABCL) share price is $3.2, making it a Buy.
AbCellera Biologics’s (ABCL) 100-Day exponential moving average is 2.49, while AbCellera Biologics’s (ABCL) share price is $3.2, making it a Buy.
AbCellera Biologics’s (ABCL) stock price is $3.2 and AbCellera Biologics’s (ABCL) 50-day simple moving average is 2.31, creating a Buy signal.
AbCellera Biologics’s (ABCL) stock price is $3.2 and AbCellera Biologics’s (ABCL) 100-day simple moving average is 2.55, creating a Buy signal.
AbCellera Biologics’s (ABCL) stock price is $3.2 and AbCellera Biologics’s (ABCL) 200-day simple moving average is 2.66, creating a Buy signal.

AbCellera Biologics (ABCL) Technical Indicators

Jun 15, 2025, 10:15 AM
Name
Value
Implied Action
RSI (14)
78.86
Sell
STOCH (9,6)
75.51
Neutral
STOCHRSI (14)
76.77
Neutral
MACD (12,26)
0.23
Sell
ADX (14)
34.71
Neutral
Williams %R
-23.05
Buy
CCI (14)
152.64
Sell
ATR (14)
0.19
-
Ultimate Oscillator
63.37
Neutral
ROC
62.44
Buy
AbCellera Biologics’s (ABCL) Relative Strength Index (RSI) is 78.86, creating a Sell signal.
AbCellera Biologics’s (ABCL) Trend Strength Indicator (ADX) is 34.71, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Commodity Channel Index (CCI) is 152.64, creating a Sell signal.
AbCellera Biologics’s (ABCL) Price Rate of Change (ROC) is 62.44, creating a Buy signal.

FAQ

Is ABCL a Buy, Hold, or Sell?
Based on ABCL’s technical indicators, ABCL is a Strong Buy.
    What is ABCL’s RSI (14)?
    ABCL’s RSI (14) is 78.86, which suggests ABCL is a Sell.
      What is ABCL’s MACD?
      ABCL’s MACD is 0.23, which suggests ABCL is a Sell.
        What is ABCL’s 5-day moving average?
        ABCL’s 5-day moving average is 3.02, which suggests ABCL is a Buy.
          What is ABCL’s 20-day moving average?
          ABCL 20-day moving average is 2.35, which suggests ABCL is a Buy.
            What is ABCL’s 50-day moving average?
            ABCL’s 50-day moving average is 2.31, which suggests ABCL is a Buy.
              What is ABCL’s 200-day moving average?
              ABCL’s 200-day moving average is 2.66, which suggests ABCL is a Buy.
                What is ABCL’s Williams % R (14)?
                ABCL’s Williams % R (14) is -23.05, which suggests ABCL is a Buy.
                  What is ABCL’s CCI (14)?
                  ABCL’s CCI (14) is 152.64, which suggests ABCL is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis